PL385415A1 - Sposób wykrywania bakteriooporności, zestaw diagnostyczny oraz zastosowanie oznaczania obecności leku i/lub produktów jego rozpadu - Google Patents

Sposób wykrywania bakteriooporności, zestaw diagnostyczny oraz zastosowanie oznaczania obecności leku i/lub produktów jego rozpadu

Info

Publication number
PL385415A1
PL385415A1 PL385415A PL38541508A PL385415A1 PL 385415 A1 PL385415 A1 PL 385415A1 PL 385415 A PL385415 A PL 385415A PL 38541508 A PL38541508 A PL 38541508A PL 385415 A1 PL385415 A1 PL 385415A1
Authority
PL
Poland
Prior art keywords
presencea
decomposition
drug
determination
products
Prior art date
Application number
PL385415A
Other languages
English (en)
Inventor
Marek Ciesielski
Original Assignee
Marek Ciesielski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marek Ciesielski filed Critical Marek Ciesielski
Priority to PL385415A priority Critical patent/PL385415A1/pl
Priority to GB0812469A priority patent/GB2460882A/en
Priority to PCT/PL2009/000066 priority patent/WO2009151346A1/en
Publication of PL385415A1 publication Critical patent/PL385415A1/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9446—Antibacterials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL385415A 2008-06-11 2008-06-11 Sposób wykrywania bakteriooporności, zestaw diagnostyczny oraz zastosowanie oznaczania obecności leku i/lub produktów jego rozpadu PL385415A1 (pl)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL385415A PL385415A1 (pl) 2008-06-11 2008-06-11 Sposób wykrywania bakteriooporności, zestaw diagnostyczny oraz zastosowanie oznaczania obecności leku i/lub produktów jego rozpadu
GB0812469A GB2460882A (en) 2008-06-11 2008-07-08 Method for determining antibiotic resistance
PCT/PL2009/000066 WO2009151346A1 (en) 2008-06-11 2009-06-10 A method for determining bacterial antibiotic resistance or bacterial susceptibility, a diagnostic kit for the detection of the antibiotic resistance and use of such diagnostic kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL385415A PL385415A1 (pl) 2008-06-11 2008-06-11 Sposób wykrywania bakteriooporności, zestaw diagnostyczny oraz zastosowanie oznaczania obecności leku i/lub produktów jego rozpadu

Publications (1)

Publication Number Publication Date
PL385415A1 true PL385415A1 (pl) 2009-12-21

Family

ID=39718147

Family Applications (1)

Application Number Title Priority Date Filing Date
PL385415A PL385415A1 (pl) 2008-06-11 2008-06-11 Sposób wykrywania bakteriooporności, zestaw diagnostyczny oraz zastosowanie oznaczania obecności leku i/lub produktów jego rozpadu

Country Status (3)

Country Link
GB (1) GB2460882A (pl)
PL (1) PL385415A1 (pl)
WO (1) WO2009151346A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102253216B (zh) * 2011-03-10 2013-12-18 北京维德维康生物技术有限公司 一种基于青霉素结合蛋白的检测β-内酰胺类抗生素的方法及专用试剂盒和试纸条
CN103713133B (zh) * 2012-09-29 2016-06-22 北京勤邦生物技术有限公司 检测螺旋霉素、链霉素、庆大霉素、新霉素的试纸条及方法
CN103645273B (zh) * 2013-12-12 2015-12-30 宁波诺威医疗器械有限公司 β-内酰胺类抗生素耐药性的检测方法、系统及其应用
US9597319B2 (en) * 2014-04-23 2017-03-21 Case Western Reserve University Compositions and methods of inhibiting metallo-β-lactamases
WO2018106546A1 (en) * 2016-12-06 2018-06-14 Silver Lake Research Corporation Methods of detection of antibiotic-resistant bacteria

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009692D0 (en) * 1990-04-30 1990-06-20 Ucb Bioproducts An enzymatic method of determining beta-lactam ring antibiotics
EP0593112B1 (en) * 1992-10-06 1998-08-26 Gist-Brocades N.V. Detection of antibiotics
US6103536A (en) * 1997-05-02 2000-08-15 Silver Lake Research Corporation Internally referenced competitive assays
BE1012049A6 (fr) * 1998-06-25 2000-04-04 Ucb Bioproducts Procede pour la determination d'antibiotique a noyau beta-lactame dans un liquide biologique.
CN200982971Y (zh) * 2005-04-15 2007-11-28 华南农业大学 青霉素快速半定量检测试纸

Also Published As

Publication number Publication date
GB2460882A (en) 2009-12-16
WO2009151346A1 (en) 2009-12-17
GB0812469D0 (en) 2008-08-13

Similar Documents

Publication Publication Date Title
EP2456891A4 (en) DIAGNOSIS, DETECTION, QUANTIFICATION UNIVERSAL MICROBIENS, AND TARGETED THERAPY ON A SAMPLE
EP2040720A4 (en) METHOD FOR DETECTION AND NEUTRALIZATION OF BACTERIA
AP3758A (en) Bicyclo[3.2.1]octyl amide derivatives and uses of same
EP1980203B8 (en) Blood sensor and blood test apparatus having the same
EP2248461A4 (en) MEDICAL REMOTE DIAGNOSIS DEVICE WITH BIOMASS AND BIOTASTATURE AND METHOD FOR THEIR USE
GB2495238B (en) System for sensing human movement and methods of using the same
ZA200906079B (en) Drug detection kit and method
EP2299904A4 (en) MEDICAL DIAGNOSTIC DEVICES AND METHODS
ZA201002989B (en) New antibodies specific of the beta-amyloid and their uses as diagnostic agents or drugs
GB0701641D0 (en) Analyte manipulation and detection
EP2503087A4 (en) Door hanging apparatus and door apparatus provided with the same
EP2188632A4 (en) APPARATUS AND METHODS FOR DIAGNOSING BACTERIAL VAGINOSIS
GB0915869D0 (en) Composition and assay method for the detection of patogenic bacteria
ZA201000447B (en) Diaphragm analysis method and use of products obtained using the method
PL385415A1 (pl) Sposób wykrywania bakteriooporności, zestaw diagnostyczny oraz zastosowanie oznaczania obecności leku i/lub produktów jego rozpadu
EP2138192A4 (en) AGENT USED TO IMPROVE THE RESISTANCE OF A LIPOSOME AGAINST A BIOLOGICAL CONSTITUENT AND A MODIFIED LIPOSOME WITH THAT AGENT
EP2303129A4 (en) DISPOSABLE PROTECTION FOR STETHOSCOPE AND METHOD THEREOF
EP1976426A4 (en) SYSTEM AND METHODS FOR MEDICAL DIAGNOSIS
EP2284283A4 (en) METHODS AND REAGENTS FOR DETECTION OF SALMONELLA SP.
EP2350001A4 (en) NEW BENZYLIDENE INDOLINOES AND THEIR MEDICAL AND DIAGNOSTIC USES
HK1157395A1 (en) Primer and probe for detection of mycobacterium intracellulare, and method for detection of mycobacterium intracellulare using the primer or the probe
EP2231866A4 (en) METHOD AND OLIGONUCLEOTIDE FOR THE DETECTION OF MASTITIS-CAUSING BACTERIA
ZA200810695B (en) Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the mage-a3-marker
EP2242858A4 (en) ISOTHERMAL DETECTION METHODS AND USES THEREOF
EP2371376A4 (en) METHODS AND REAGENTS FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INSULIN RESISTANCE

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)